X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (140669) 140669
Newsletter (1345) 1345
Newspaper Article (646) 646
Magazine Article (223) 223
Book / eBook (144) 144
Book Chapter (72) 72
Web Resource (24) 24
Conference Proceeding (20) 20
Publication (20) 20
Dissertation (13) 13
Book Review (9) 9
Government Document (3) 3
Reference (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (126018) 126018
lung neoplasms - pathology (71759) 71759
female (71135) 71135
male (68937) 68937
middle aged (55256) 55256
oncology (47690) 47690
aged (47182) 47182
adult (36179) 36179
cancer (30340) 30340
lung cancer (28939) 28939
animals (27097) 27097
carcinoma, non-small-cell lung - pathology (22436) 22436
prognosis (21898) 21898
neoplasm staging (19918) 19918
mice (18675) 18675
metastasis (18043) 18043
lung neoplasms - drug therapy (17924) 17924
lung neoplasms - secondary (17852) 17852
aged, 80 and over (17513) 17513
lung neoplasms - genetics (17013) 17013
cell line, tumor (16940) 16940
tumors (16706) 16706
lung neoplasms - metabolism (14534) 14534
chemotherapy (14302) 14302
lung neoplasms - surgery (13943) 13943
respiratory system (13943) 13943
expression (13842) 13842
lung-cancer (13396) 13396
pathology (13285) 13285
surgery (13234) 13234
adenocarcinoma - pathology (13157) 13157
retrospective studies (12543) 12543
research (12408) 12408
treatment outcome (12100) 12100
carcinoma (11832) 11832
immunohistochemistry (11829) 11829
lung neoplasms - diagnosis (11768) 11768
lung neoplasms - mortality (11353) 11353
survival (11071) 11071
lung neoplasms - diagnostic imaging (10427) 10427
care and treatment (10254) 10254
analysis (9987) 9987
apoptosis (9702) 9702
lung cancer, non-small cell (9699) 9699
tomography, x-ray computed (9450) 9450
lung - pathology (9379) 9379
carcinoma, non-small-cell lung - drug therapy (9078) 9078
neoplasm metastasis (8833) 8833
diagnosis (8769) 8769
survival rate (8634) 8634
adenocarcinoma (8262) 8262
mutation (8241) 8241
carcinoma, squamous cell - pathology (8174) 8174
cell biology (8170) 8170
gene expression regulation, neoplastic (8132) 8132
lung (8028) 8028
antineoplastic combined chemotherapy protocols - therapeutic use (7880) 7880
cell lung-cancer (7810) 7810
carcinoma, non-small-cell lung - genetics (7570) 7570
follow-up studies (7434) 7434
gene expression (7379) 7379
diagnosis, differential (7358) 7358
lymphatic metastasis (7271) 7271
lung neoplasms - therapy (7262) 7262
health aspects (7162) 7162
risk factors (7075) 7075
survival analysis (7064) 7064
genetic aspects (6854) 6854
breast-cancer (6655) 6655
radiology, nuclear medicine & medical imaging (6501) 6501
proteins (6492) 6492
medicine & public health (6490) 6490
time factors (6203) 6203
carcinoma, non-small-cell lung - mortality (6160) 6160
biopsy (6130) 6130
research article (6074) 6074
breast neoplasms - pathology (6053) 6053
patients (6053) 6053
antineoplastic agents - therapeutic use (6022) 6022
tumor cells, cultured (5929) 5929
mice, nude (5925) 5925
metastases (5824) 5824
breast cancer (5796) 5796
non-small cell lung cancer (5795) 5795
radiotherapy (5782) 5782
cell proliferation (5772) 5772
medicine (5632) 5632
biochemistry & molecular biology (5553) 5553
neoplasm invasiveness (5510) 5510
development and progression (5505) 5505
cancer therapies (5498) 5498
therapy (5464) 5464
carcinoma, non-small-cell lung - metabolism (5357) 5357
adolescent (5306) 5306
neoplasms - pathology (5173) 5173
disease-free survival (5152) 5152
medical prognosis (5151) 5151
growth (5101) 5101
antineoplastic agents - pharmacology (5063) 5063
hematology, oncology and palliative medicine (5053) 5053
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (54) 54
Online Resources - Online (23) 23
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
St. Michael's Hospital - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Reference (3) 3
Lakeridge Health Sciences - Online (2) 2
Providence Healthcare - Reference (2) 2
Scarborough Hospital - Online (2) 2
West Park Healthcare Centre - Stacks (2) 2
Humber River Regional Hospital - Church Reference (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
New College (Ivey) - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (131553) 131553
Japanese (4557) 4557
Chinese (3162) 3162
German (2311) 2311
French (2226) 2226
Russian (1504) 1504
Spanish (946) 946
Italian (721) 721
Polish (429) 429
Portuguese (216) 216
Hungarian (159) 159
Czech (114) 114
Romanian (103) 103
Dutch (84) 84
Danish (79) 79
Croatian (73) 73
Turkish (72) 72
Bulgarian (48) 48
Norwegian (47) 47
Korean (36) 36
Finnish (33) 33
Hebrew (30) 30
Serbian (30) 30
Swedish (22) 22
Ukrainian (19) 19
Slovak (18) 18
Lithuanian (17) 17
Icelandic (11) 11
Arabic (3) 3
Latvian (2) 2
Bosnian (1) 1
Georgian (1) 1
Greek (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: a cancer journal for clinicians, ISSN 0007-9235, 2016, Volume 66, Issue 5, pp. 408 - 436
... when most invasive cancers in most anatomic sites might be prevented with similar interventions. This review, amassed with the collective expertise of pathology colleagues... 
carcinoma in situ | dysplasia | intraepithelial neoplasia | preinvasive neoplasia | precancer | HIGH-GRADE DYSPLASIA | URINARY-BLADDER | BARRETTS-ESOPHAGUS | HUMAN-PAPILLOMAVIRUS | INTRADUCTAL CARCINOMA | CARCINOMA IN-SITU | PAPILLARY UROTHELIAL HYPERPLASIA | ONCOLOGY | SINGLE ACADEMIC CENTER | TERM-FOLLOW-UP | NECK-CANCER IMPLICATIONS | Humans | Lung Neoplasms - metabolism | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Esophageal Neoplasms - pathology | Breast Neoplasms - therapy | American Cancer Society | Uterine Cervical Neoplasms - metabolism | Skin Neoplasms - diagnosis | Urinary Bladder Neoplasms - pathology | Female | Ovarian Neoplasms - metabolism | Uterine Cervical Neoplasms - therapy | Skin Neoplasms - pathology | Prostatic Neoplasms - pathology | Uterine Cervical Neoplasms - diagnosis | Skin Neoplasms - therapy | Carcinoma in Situ - pathology | Ovarian Neoplasms - diagnosis | Pancreatic Neoplasms - pathology | Risk Factors | Head and Neck Neoplasms - therapy | Lung Neoplasms - therapy | Carcinoma in Situ - therapy | Head and Neck Neoplasms - pathology | Skin Neoplasms - metabolism | Breast Neoplasms - pathology | Ovarian Neoplasms - therapy | Head and Neck Neoplasms - diagnosis | Breast Neoplasms - diagnosis | Carcinoma in Situ - diagnosis | Carcinoma in Situ - metabolism | Lung Neoplasms - diagnosis | Population Surveillance | Prevention | Care and treatment | Gastrointestinal system | Practice | Pathologists | Metastasis | Patients | Health aspects | Cervical cancer | Risk factors | Pathology | Usage | Diagnosis | Tumors | Medical diagnosis | Cancer
Journal Article
Seminars in oncology, ISSN 0093-7754, 2015, Volume 42, Issue 6, pp. 801 - 819
The fibroblast growth factor receptor (FGFR) pathway plays a major role in several biological processes, from organogenesis to metabolism homeostasis and... 
BREAST-CANCER | LUNG-CANCER | IN-VITRO | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RESISTANCE | GENE AMPLIFICATION | POTENTIAL THERAPEUTIC TARGET | PROGNOSTIC-SIGNIFICANCE | ANTITUMOR-ACTIVITY | EXPRESSION | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Brain Neoplasms - pathology | Fibroblast Growth Factors - genetics | Brain Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Gastrointestinal Neoplasms - pathology | Glioblastoma - genetics | Receptors, Fibroblast Growth Factor - genetics | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Gastrointestinal Neoplasms - metabolism | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - drug therapy | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Thoracic Neoplasms - pathology | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Thoracic Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Breast Neoplasms - genetics | Thoracic Neoplasms - genetics | Breast Neoplasms - pathology | Glioblastoma - pathology | Receptors, Fibroblast Growth Factor - metabolism | Head and Neck Neoplasms - genetics | Fibroblast Growth Factors - antagonists & inhibitors | Thoracic Neoplasms - drug therapy | Glioblastoma - drug therapy | Neoplasms - pathology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
Cancer causes & control, ISSN 1573-7225, 2008, Volume 20, Issue 4, pp. 417 - 435
Background Population-based cancer registry data from the Surveillance, Epidemiology, and End Results (SEER) Program at the National Cancer Institute (NCI) are... 
Socioeconomic status | Prophets | Mortality | Censuses | Cancer incidence | Breast cancer | Socioeconomics | Educational attainment | Lung neoplasms | Cancer | NLMS | SES | Poverty | Hematology | Rural/urban | Income | Oncology | Record linkage | Public Health/Gesundheitswesen | Epidemiology | Unemployment | Biomedicine general | Biomedicine | Education | Race/ethnicity | Cancer Research | SEER | Stage | Health disparities | RACIAL-DIFFERENCES | BREAST-CANCER | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PROSTATE-CANCER | UNITED-STATES | CERVICAL-CANCER | RESULTS PROGRAM | US WOMEN | SOCIAL-CLASS | DEATH INDEX | ONCOLOGY | COLORECTAL-CANCER | Melanoma - epidemiology | Lung Neoplasms - ethnology | United States - epidemiology | Uterine Cervical Neoplasms - ethnology | Lung Neoplasms - mortality | Humans | Survivors - statistics & numerical data | Uterine Cervical Neoplasms - epidemiology | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Incidence | Neoplasms - ethnology | Female | Registries | Medical Record Linkage | Breast Neoplasms - ethnology | Uterine Cervical Neoplasms - mortality | Breast Neoplasms - epidemiology | Ethnic Groups - statistics & numerical data | Prostatic Neoplasms - pathology | SEER Program | Melanoma - ethnology | Neoplasms - mortality | Prostatic Neoplasms - ethnology | Melanoma - pathology | Prostatic Neoplasms - mortality | Social Class | Prostatic Neoplasms - epidemiology | Lung Neoplasms - epidemiology | Breast Neoplasms - pathology | Healthcare Disparities | Breast Neoplasms - mortality | Neoplasm Staging | Neoplasms - pathology | Longitudinal Studies | Neoplasms - epidemiology | Cohort Studies | Melanoma - mortality | Social classes | Usage | Demographic aspects | Social aspects | Health aspects | Epidemiologic methods | Rural | ethnicity | Original Paper | urban | Race
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT) for metastases limited in number and extent.... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
Human pathology, ISSN 0046-8177, 2013, Volume 44, Issue 11, pp. 2563 - 2570
Summary BRAF mutation is seen in a variety of human neoplasms including cutaneous malignant melanoma, papillary thyroid carcinoma, colorectal carcinoma, non... 
Pathology | Immunohistochemistry | Anti–B-Raf | BRAF V600E | VE1 | Glioma | Melanoma | Thyroid carcinoma | Anti-B-Raf | PROTEIN | IMPROVED SURVIVAL | PATHOLOGY | CANCER | TUMORS | THERAPY | MEK INHIBITION | GENE | MUTANT BRAF | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Humans | Lung Neoplasms - metabolism | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Mutation, Missense | Breast Neoplasms - metabolism | Glioma - metabolism | Glioma - genetics | Ovarian Neoplasms - genetics | Gastrointestinal Neoplasms - pathology | Neoplasms - genetics | DNA Mutational Analysis | Melanoma - genetics | Glioma - pathology | Sensitivity and Specificity | Biomarkers, Tumor - metabolism | Female | Ovarian Neoplasms - metabolism | Carcinoma - pathology | Antibodies, Monoclonal - immunology | Proto-Oncogene Proteins B-raf - metabolism | Gastrointestinal Neoplasms - metabolism | Lung Neoplasms - genetics | Melanoma - metabolism | Mutant Proteins - genetics | Mutant Proteins - metabolism | Melanoma - pathology | Thyroid Neoplasms - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Proto-Oncogene Proteins B-raf - genetics | Carcinoma - genetics | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasms - pathology | Amino Acid Substitution | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Carcinoma | Gene mutations | Gliomas | Thyroid diseases | Monoclonal antibodies | Genetic aspects | Comparative analysis | Lung cancer, Non-small cell | Cancer | Breast cancer | Mutation | Tumors | Skin cancer
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Abstract Purpose To assess preliminary safety and efficacy results of the anti-programmed cell death ligand-1 (anti-PD-L1) durvalumab in combination with... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2011, Volume 331, Issue 6017, pp. 593 - 596
Satellite repeats in heterochromatin are transcribed into noncoding RNAs that have been linked to gene silencing and maintenance of chromosomal integrity.... 
Tumor cell line | Artificial satellites | RNA | Lungs | Genes | Liver | REPORTS | Cell lines | Pancreas | Tumors | Cancer | RNAS | ELEMENTS | DIFFERENTIATION | DATABASE | PERVASIVE TRANSCRIPTION | MULTIDISCIPLINARY SCIENCES | Colonic Neoplasms - genetics | RNA, Untranslated - metabolism | Humans | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Gene Expression Profiling | RNA, Neoplasm - metabolism | RNA, Untranslated - genetics | Heterochromatin - chemistry | Carcinoma, Pancreatic Ductal - genetics | Ovarian Neoplasms - genetics | DNA Methylation | Carcinoma in Situ - genetics | Prostatic Neoplasms - genetics | Neoplasms - genetics | Neurosecretory Systems - metabolism | Female | Transcription, Genetic | Lung Neoplasms - genetics | Prostatic Neoplasms - pathology | Gene Expression | Carcinoma in Situ - pathology | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - pathology | Animals | Heterochromatin - genetics | Long Interspersed Nucleotide Elements | Mice, Nude | Colonic Neoplasms - pathology | RNA, Neoplasm - genetics | DNA, Satellite - genetics | Mice | DNA, Neoplasm - genetics | Neoplasms - pathology | Epithelial cells | Analysis | Microsatellites (Genetics) | Genetic aspects | Gene expression | Health aspects | Biomarkers | Chromatin | Pancreatic cancer | Deoxyribonucleic acid--DNA
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2008, Volume 60, Issue 3, pp. 379 - 387
Background Previous reports regarding the rates at which various internal tumors metastasize to the skin have been limited and have only included the Caucasian... 
Dermatology | LUNG-CANCER | PROGNOSTIC-FACTORS | ASIAN ETHNICITY | BREAST-CANCER METASTASIS | SKIN-ASSOCIATED CHEMOKINE | BASAL-CELL CARCINOMA | WHITE WOMEN | DRINKING-WATER | AFRICAN-AMERICAN | CHINESE WOMEN | DERMATOLOGY | Immunohistochemistry | Lung Neoplasms - ethnology | Academic Medical Centers - statistics & numerical data | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Carcinoma, Transitional Cell - secondary | Lung Neoplasms - pathology | Mouth Neoplasms - metabolism | Carcinoma, Hepatocellular - secondary | Carcinoma, Transitional Cell - ethnology | Breast Neoplasms - metabolism | Carcinoma, Squamous Cell - ethnology | Gastrointestinal Neoplasms - pathology | Mouth Neoplasms - ethnology | Adenocarcinoma - metabolism | Urinary Bladder Neoplasms - pathology | Liver Neoplasms - pathology | Retrospective Studies | Adenocarcinoma - ethnology | Breast Neoplasms - ethnology | Urinary Bladder Neoplasms - metabolism | Carcinoma, Hepatocellular - ethnology | Gastrointestinal Neoplasms - metabolism | Receptors, CCR10 - metabolism | Skin Neoplasms - ethnology | Carcinoma, Transitional Cell - metabolism | Adenocarcinoma - secondary | Receptors, CXCR4 - metabolism | Skin Neoplasms - metabolism | Liver Neoplasms - ethnology | Breast Neoplasms - pathology | Taiwan - epidemiology | Liver Neoplasms - metabolism | Skin Neoplasms - secondary | Mouth Neoplasms - pathology | Carcinoma, Squamous Cell - secondary | Gastrointestinal Neoplasms - ethnology | Asian Continental Ancestry Group - statistics & numerical data | Carcinoma, Hepatocellular - metabolism | Urinary Bladder Neoplasms - ethnology | Medical colleges | Hospitals | Metastasis | Medical centers | Cancer
Journal Article
Gynecologic oncology, ISSN 0090-8258, 2013, Volume 131, Issue 1, pp. 36 - 41
Abstract Objective We evaluated the clinical outcome and prognostic factors for post-relapse survival (PRS) in a large retrospective series of ovarian cancer... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Anatomic site of disease | Favourable prognosis | Recurrent ovarian cancer | Localized relapse | Secondary debulking surgery | SURVIVAL | METASTASIS | SECONDARY CYTOREDUCTIVE SURGERY | IDENTIFICATION | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | 2ND-LINE | THERAPY | CISPLATIN | ONCOLOGY | RECURRENT | CARCINOMA | Lymph Nodes - pathology | Follow-Up Studies | Lymph Nodes - surgery | Humans | Middle Aged | Brain Neoplasms - pathology | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Brain Neoplasms - surgery | Neoplasm Recurrence, Local - pathology | Platinum Compounds - therapeutic use | Young Adult | Brain Neoplasms - secondary | Lung Neoplasms - secondary | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Liver Neoplasms - secondary | Carcinoma - secondary | Peritoneal Neoplasms - secondary | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Neoplasm Recurrence, Local - therapy | Peritoneal Neoplasms - surgery | Neoplasms, Glandular and Epithelial - therapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Splenic Neoplasms - surgery | Splenic Neoplasms - pathology | Carcinoma, Ovarian Epithelial | Ovarian Neoplasms - therapy | Carcinoma - therapy | Aged | Neoplasm Staging | Splenic Neoplasms - secondary | Care and treatment | Cancer patients | Prognosis | Patient outcomes | Ovarian cancer
Journal Article